Almost exactly 33 years
after the publication of his pioneering paper on positive airway pressure for
sleep apnoea (PAP) in The Lancet, Colin Sullivan continues to extend the
boundaries of sleep medicine. In those three decades, PAP has gone from an
obscure treatment available to few to an effective, portable treatment that has
improved the sleep, and thus lifestyles, of millions worldwide.
Sullivan and his team undertook experiments with
dogs on airway obstruction, and created a mask for use on human patients. Air
pressure was controlled with a circuit that raised pressure until passive obstruction
of the airway was cleared. His first test patient was a 43-year-old
construction worker who did not want a tracheostomy—back then the only
treatment. At very low pressures, PAP cleared the man's airway and allowed him
to sink into a deeper sleep, as well as being sleep-free the next day. An
elated Sullivan tried the technique on four other patients, and these findings
formed the basis for his 1981 Lancet paper: Reversal of obstructive
sleep apnoea by continuous positive airway pressure applied through the nares.
“When we were writing the paper,” says Dr. Sullivan,
“we had no idea how many people had sleep apnea”.
Abstract from
this great article: Five patients with severe obstructive sleep apnoea were
treated with continuous positive airway pressure (CPAP) applied via a
comfortable nose mask through the nares. Low levels of pressure (range 4·5-10
cm H2O) completely prevented upper airway
occlusion during sleep in each patient and allowed an entire night of
uninterrupted sleep. Continuous positive airway pressure applied in this manner
provides a pneumatic splint for the nasopharyngeal airway and is a safe, simple
treatment for the obstructive sleep apnoea syndrome.
No comments:
Post a Comment